Literature DB >> 2566221

Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment.

A Oxholm1, P Oxholm, B Staberg, K Bendtzen.   

Abstract

Biopsies from lesional and unaffected skin of 6 patients with psoriasis, taken before and during treatment with psoralen plus UVA (PUVA) were examined immunohistologically, using partially purified polyclonal antibodies to crude supernatants of activated human blood monocytes. By absorption with recombinant derived human monokines, we were able to demonstrate that interleukin-6 (IL-6) (but not IL-1 alpha or IL-1 beta) was located in a laminar and granular pattern in stratum corneum, and on epidermal cell membranes in the viable cellular epidermis. Before PUVA treatment, the intensity and the extension of staining for IL-6 were both markedly increased in lesional skin compared with uninvolved skin. A weaker staining for IL-6 was observed in lesional skin, simultaneous with the clinical improvement of psoriasis. The staining patterns for IL-6 in biopsies from cleared lesional skin and uninvolved psoriatic skin were identical at the conclusion of therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566221

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  6 in total

1.  Psoriatic skin reveals the in vivo presence of an epidermal IL-1 inhibitor.

Authors:  N I Kim; K D Cooper; G J Fisher; O Baadsgaard; J J Voorhees; C Hammerberg
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

2.  IL-6 Gene Expression as a Marker of Pathological State in Psoriasis and Psoriatic Arthritis.

Authors:  V V Sobolev; E V Denisova; S N Chebysheva; N A Geppe; I M Korsunskaya
Journal:  Bull Exp Biol Med       Date:  2022-05-27       Impact factor: 0.804

3.  Cytokine expression in psoriatic skin lesions during PUVA therapy.

Authors:  A K Olaniran; B S Baker; D G Paige; J J Garioch; A V Powles; L Fry
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

4.  Detection of inflammatory cytokines in psoriatic skin.

Authors:  Y Yoshinaga; M Higaki; S Terajima; E Ohkubo; T Nogita; N Miyasaka; M Kawashima
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

5.  Interleukin-6 in psoriasis: expression and mitogenicity studies.

Authors:  J T Elder; C I Sartor; D K Boman; S Benrazavi; G J Fisher; M R Pittelkow
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

6.  Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis.

Authors:  Anna Zalewska; Ewa Głowacka; Janina Wyczółkowska; Henryk Tchórzewski; Joanna Narbutt; Anna Sysa-Jedrzejowska
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.